NCBiotech News

North Carolina’s strength in the life sciences and its strong business climate have landed it, again, among the nation’s best on Business Facilities Magazine's 16th Annual Rankings Report for 2020.

Greensboro diagnostics and drug screening company Carolina Liquid Chemistries (CLC) is now selling COVID-19 test kits.

The NCBiotech-supported Summer Undergraduate Research Program at Western Carolina University has adapted well to the world of digital communication.

Raleigh pharmaceutical upstart 9 Meters Biopharma has secured patent protection for its potential gastrointestinal drug for additional use in treating lung disease. 

RTP oncology company G1 Therapeutics has out-licensed a potential drug for treating certain breast and lung cancers to a Massachusetts startup in a deal that could be worth more than $300 million.

RTP-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic researchers as part of its efforts to accelerate research on how COVID-19 is impacting the healthcare industry and related treatment.

Winston-Salem's EncepHeal Therapeutics has landed a federal grant to support development of its novel medications for cocaine addiction.

Less than two years after launching, Avior Bio is kicking off its first human trial for a novel drug therapy treating pruritus, or chronic itchy skin

RTP-based Panaceutics Nutrition has launched I-Vive, a new line of single-serve nutritional products compounded for the general public

North Carolina’s global leadership in biomanufacturing has drawn another spotlight with a White House announcement that President Donald Trump will be visiting the Triangle on Monday, July 27, to a company involved in producing COVID-19 vaccine.

Medicago – with a biomanufacturing facility in Durham –  is using a form of tobacco to produce an experimental plant-based vaccine for COVID-19.

Burlington-based life science conglomerate LabCorp is the latest company to provide a test for COVID-19.

The rapid global march of the coronavirus that began in Wuhan, China several months ago could be slowed by researchers and biotech firms 7,770 miles away – in the Research Triangle of North Carolina.

Fresenius Kabi, a global health care company based in Germany, hosted a topping off ceremony last week to celebrate the $100 million expansion of its pharmaceutical manufacturing campus in Wilson.

Grifols, a global biotherapeutics company with major operations in North Carolina, announced today that it will begin production of a plasma-derived treatment to battle the Ebola virus for the country of Liberia at its flagship Clayton manufacturing site.